Market Overview:
The global enalapril market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of hypertension, increasing awareness about hypertension and its treatment, and growing demand for generic drugs. By type, the 2.5mg segment is expected to account for the largest share of the global enalapril market in 2018, followed by the 10mg segment. By application, hospitals are expected to account for the largest share of the global enalapril market in 2018, followed by drugs stores.
Product Definition:
Enalapril is a drug used to treat high blood pressure, congestive heart failure, and other conditions. It belongs to a class of drugs known as ACE inhibitors.
2.5mg:
The 2.5mg tablets are white in color and are shaped like a diamond with a flat base.
5mg:
Enalapril is used to treat heart failure, hypertension, and angina pectoris. It is also used as an outpatient treatment for pulmonary embolism and deep vein thrombosis. The drug works by improving the function of the kidney by reducing blood flow to it; this reduction in blood flow causes pain in the chest due to reduced oxygen supply.
Application Insights:
Drugs store was the largest application segment with a revenue share of over 60% in 2017. Enalapril is used for the treatment of hypertension and heart failure. Increasing awareness about cardiovascular diseases coupled with rising number of deaths due to these diseases is expected to drive demand for enalapril over the forecast period.
The hospital segment is also anticipated to witness significant growth owing to increasing prevalence of Cardiovascular Diseases (CVDs) globally, especially in high-income countries such as Germany, Japan and France where nearly half of all deaths occur due CVDs. In addition, growing aging population prone towards CVDs will further boost market growth over the forecast period.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels and presence of key manufacturers. The region will retain its dominant position throughout the forecast years on account of increasing demand for blood pressure drugs in countries, such as the U.S., and Mexico. In addition, growing geriatric population prone to cardiac diseases is expected to fuel product demand over the next eight years.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast period due to rising healthcare expenditure by governments & private agencies coupled with improving infrastructure in emerging economies including India and China. Enalapril has a wide application scope which makes it suitable for treating various disorders, such as heart failure, hypertension, etc.
In terms of volume consumption, Europe accounts for approximately 25% share followed by North America owing to higher disease prevalence rates coupled with better reimbursement scenario in European countries than U.S.
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases: The increasing prevalence of hypertension and other heart diseases is one of the key growth drivers for the enalapril market. According to a study by the World Health Organization (WHO), it is estimated that around 17.5 million people died from cardiovascular diseases in 2015, which accounted for 31% of all global deaths. This number is expected to increase in the coming years due to the rising incidence of lifestyle-related disorders such as obesity and diabetes mellitus. This will create a high demand for drugs such as enalapril, which are used for treating these conditions.
- Growing geriatric population: The growing geriatric population is another major driver for the enalapril market. With advances in medical technology and healthcare facilities, people are living longer than ever before. This has resulted in an increase in the number of elderly people who are susceptible to various heart conditions such as hypertension, congestive heart failure (CHF), and myocardial infarction (MI). As a result, there is a growing demand for drugs such as enalapril that can help treat these conditions effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enalapril Market Research Report
By Type
2.5mg, 5mg, 10mg, 20mg
By Application
Hospital, Drugs Store
By Companies
Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Krka Dd Novo Mesto, Lek Pharmaceuticals D D, Mylan Pharmaceuticals Inc, Ranbaxy Laboratories Ltd, Sandoz Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceuticals Usa Inc, Watson Laboratories Inc, Wockhardt Americas Inc, Biovail Laboratories International Srl, Bedford Laboratories Div Ben Venue Laboratories Inc, Hikma Farmaceutica (Portugal) Sa, Hospira Inc, Teva Parenteral Medicines Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Enalapril Market Report Segments:
The global Enalapril market is segmented on the basis of:
Types
2.5mg, 5mg, 10mg, 20mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Apotex Inc
- Apothecon Inc Div Bristol Myers Squibb
- Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
- Krka Dd Novo Mesto
- Lek Pharmaceuticals D D
- Mylan Pharmaceuticals Inc
- Ranbaxy Laboratories Ltd
- Sandoz Inc
- Taro Pharmaceutical Industries Ltd
- Teva Pharmaceuticals Usa Inc
- Watson Laboratories Inc
- Wockhardt Americas Inc
- Biovail Laboratories International Srl
- Bedford Laboratories Div Ben Venue Laboratories Inc
- Hikma Farmaceutica (Portugal) Sa
- Hospira Inc
- Teva Parenteral Medicines Inc
Highlights of The Enalapril Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5mg
- 5mg
- 10mg
- 20mg
- By Application:
- Hospital
- Drugs Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enalapril Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enalapril is a medication used to treat high blood pressure. It works by reducing the amount of fluid in your blood.
Some of the major players in the enalapril market are Apotex Inc, Apothecon Inc Div Bristol Myers Squibb, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Krka Dd Novo Mesto, Lek Pharmaceuticals D D, Mylan Pharmaceuticals Inc, Ranbaxy Laboratories Ltd, Sandoz Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceuticals Usa Inc, Watson Laboratories Inc, Wockhardt Americas Inc, Biovail Laboratories International Srl, Bedford Laboratories Div Ben Venue Laboratories Inc, Hikma Farmaceutica (Portugal) Sa, Hospira Inc, Teva Parenteral Medicines Inc.
The enalapril market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enalapril Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Enalapril Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Enalapril Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Enalapril Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Enalapril Market Size & Forecast, 2018-2028
4.5.1 Enalapril Market Size and Y-o-Y Growth
4.5.2 Enalapril Market Absolute $ Opportunity
Chapter 5 Global Enalapril Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Enalapril Market Size Forecast by Type
5.2.1 2.5mg
5.2.2 5mg
5.2.3 10mg
5.2.4 20mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Enalapril Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Enalapril Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enalapril Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enalapril Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Enalapril Analysis and Forecast
9.1 Introduction
9.2 North America Enalapril Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Enalapril Market Size Forecast by Type
9.6.1 2.5mg
9.6.2 5mg
9.6.3 10mg
9.6.4 20mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Enalapril Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Enalapril Analysis and Forecast
10.1 Introduction
10.2 Europe Enalapril Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Enalapril Market Size Forecast by Type
10.6.1 2.5mg
10.6.2 5mg
10.6.3 10mg
10.6.4 20mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Enalapril Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Enalapril Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Enalapril Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Enalapril Market Size Forecast by Type
11.6.1 2.5mg
11.6.2 5mg
11.6.3 10mg
11.6.4 20mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Enalapril Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Enalapril Analysis and Forecast
12.1 Introduction
12.2 Latin America Enalapril Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Enalapril Market Size Forecast by Type
12.6.1 2.5mg
12.6.2 5mg
12.6.3 10mg
12.6.4 20mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Enalapril Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Enalapril Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Enalapril Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Enalapril Market Size Forecast by Type
13.6.1 2.5mg
13.6.2 5mg
13.6.3 10mg
13.6.4 20mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Enalapril Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enalapril Market: Competitive Dashboard
14.2 Global Enalapril Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Apotex Inc
14.3.2 Apothecon Inc Div Bristol Myers Squibb
14.3.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
14.3.4 Krka Dd Novo Mesto
14.3.5 Lek Pharmaceuticals D D
14.3.6 Mylan Pharmaceuticals Inc
14.3.7 Ranbaxy Laboratories Ltd
14.3.8 Sandoz Inc
14.3.9 Taro Pharmaceutical Industries Ltd
14.3.10 Teva Pharmaceuticals Usa Inc
14.3.11 Watson Laboratories Inc
14.3.12 Wockhardt Americas Inc
14.3.13 Biovail Laboratories International Srl
14.3.14 Bedford Laboratories Div Ben Venue Laboratories Inc
14.3.15 Hikma Farmaceutica (Portugal) Sa
14.3.16 Hospira Inc
14.3.17 Teva Parenteral Medicines Inc
